Expression of biologically active polypeptides in duckweed

Details for Australian Patent Application No. 2001288226 (hide)

Owner Biolex, Inc.

Inventors Gasdaska, John; Dickey, Lynn; Stomp, Anne-Marie

Agent Spruson & Ferguson

Pub. Number AU-B-2001288226

PCT Pub. Number WO02/10414

Priority 60/221,705 31.07.00 US; 60/293,330 23.05.01 US

Filing date 26 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 26 July 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

26 July 2007 Application Accepted

  Published as AU-B-2001288226

3 January 2008 Standard Patent Sealed

13 March 2008 Alteration of Name

  The name of the patentee has been altered to Biolex Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288227-ANTIVESICANT COMPOUNDS AND METHODS OF MAKING AND USING THEREOF

2001288225